Literature DB >> 22859292

Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome.

Eleni Kandaraki1, Antonis Chatzigeorgiou, Christina Piperi, Eleni Palioura, Sotiria Palimeri, Penelope Korkolopoulou, Michael Koutsilieris, Athanasios G Papavassiliou.   

Abstract

Glyoxalase detoxification system composed of glyoxalase (GLO)-I and GLO-II is ubiquitously expressed and implicated in the protection against cellular damage because of cytotoxic metabolites such as advanced glycation end products (AGEs). Recently, ovarian tissue has emerged as a new target of excessive AGE deposition and has been associated with either a high AGE diet in experimental animals or hyperandrogenic disorders such as polycystic ovarian syndrome (PCOS) in humans. This study was designed to investigate the impact of dietary AGEs and androgens in rat ovarian GLO-I activity of normal nonandrogenized (NAN, group A, n = 18) and androgenized prepubertal (AN) rats (group B, n = 29). Both groups were further randomly assigned, either to a high-AGE (HA) or low-AGE (LA) diet for 3 months. The activity of ovarian GLO-I was significantly reduced in normal NAN animals fed an HA diet compared with an LA diet (p = 0.006). Furthermore, GLO-I activity was markedly reduced in AN animals compared with NAN (p ≤ 0.001) when fed with the corresponding diet type. In addition, ovarian GLO-I activity was positively correlated with the body weight gain (r(s) = 0.533, p < 0.001), estradiol (r(s) = 0.326, p = 0.033) and progesterone levels (r(s) = 0.500, p < 0.001). A negative correlation was observed between GLO-I activity and AGE expression in the ovarian granulosa cell layer of all groups with marginal statistical significance (r(s) = -0.263, p = 0.07). The present data demonstrate that ovarian GLO-I activity may be regulated by dietary composition and androgen levels. Modification of ovarian GLO-I activity, observed for the first time in this androgenized prepubertal rat model, may present a contributing factor to the reproductive dysfunction characterizing PCOS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859292      PMCID: PMC3510295          DOI: 10.2119/molmed.2012.00293

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  32 in total

1.  Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice.

Authors:  Melpomeni Peppa; Harold Brem; Paul Ehrlich; Jian-Gang Zhang; Weijing Cai; Zhu Li; Anca Croitoru; Swan Thung; Helen Vlassara
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

Review 2.  The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

3.  Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose.

Authors:  Ki Mo Kim; Young Sook Kim; Dong Ho Jung; Jun Lee; Jin Sook Kim
Journal:  Exp Cell Res       Date:  2011-10-21       Impact factor: 3.905

4.  Glyoxalase activities in human tumour cell lines in vitro.

Authors:  F Ayoub; M Zaman; P Thornalley; J Masters
Journal:  Anticancer Res       Date:  1993 Jan-Feb       Impact factor: 2.480

5.  Evidence that carbonyl stress by methylglyoxal exposure induces DNA damage and spindle aberrations, affects mitochondrial integrity in mammalian oocytes and contributes to oocyte ageing.

Authors:  Carla Tatone; Tanja Heizenrieder; Giovanna Di Emidio; Patrick Treffon; Fernanda Amicarelli; Thorsten Seidel; Ursula Eichenlaub-Ritter
Journal:  Hum Reprod       Date:  2011-05-09       Impact factor: 6.918

6.  Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Christina Piperi; Anastasios Kalofoutis; George Creatsas
Journal:  Clin Endocrinol (Oxf)       Date:  2005-01       Impact factor: 3.478

7.  Activity changes of glyoxalases I-II and glutathione reductase in regenerating rat liver.

Authors:  G B Principato; P Locci; G Rosi; V Talesa; E Giovannini
Journal:  Biochem Int       Date:  1983-02

8.  Advanced glycoxidation end products in commonly consumed foods.

Authors:  Teresia Goldberg; Weijing Cai; Melpomeni Peppa; Veronique Dardaine; Bantwal Suresh Baliga; Jaime Uribarri; Helen Vlassara
Journal:  J Am Diet Assoc       Date:  2004-08

9.  Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study.

Authors:  D M Ratliff; D J Vander Jagt; R P Eaton; D L Vander Jagt
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

Review 10.  Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation.

Authors:  P J Thornalley
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  13 in total

Review 1.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

2.  Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells.

Authors:  Eleni A Kandaraki; Antonios Chatzigeorgiou; Efstathia Papageorgiou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou; Michael Koutsilieris; Evanthia Diamanti-Kandarakis
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-15

3.  Advanced glycation end-products and insulin signaling in granulosa cells.

Authors:  Evanthia Diamanti-Kandarakis; Antonios Chatzigeorgiou; Efstathia Papageorgiou; Dimitrios Koundouras; Michael Koutsilieris
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-07

4.  Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.

Authors:  Kehinde S Olaniyi; Stephanie E Areloegbe; Mosunmola B Oyeleke
Journal:  Endocrine       Date:  2022-09-16       Impact factor: 3.925

Review 5.  Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?

Authors:  Deepika Garg; Zaher Merhi
Journal:  Nutrients       Date:  2015-12-04       Impact factor: 5.717

6.  Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.

Authors:  Chan Meng
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

Review 7.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28

Review 8.  Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management.

Authors:  Sotiria Palimeri; Eleni Palioura; Evanthia Diamanti-Kandarakis
Journal:  Diabetes Metab Syndr Obes       Date:  2015-09-01       Impact factor: 3.168

9.  Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.

Authors:  Stratigoula Sakellariou; Paraskevi Fragkou; Georgia Levidou; Antonios N Gargalionis; Christina Piperi; Georgia Dalagiorgou; Christos Adamopoulos; Angelica Saetta; George Agrogiannis; Irini Theohari; Stavros Sougioultzis; Panagiota Tsioli; Ioannis Karavokyros; Nikolaos Tsavaris; Ioannis D Kostakis; Adamantia Zizi-Serbetzoglou; Gerasimos P Vandoros; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  BMC Cancer       Date:  2016-03-01       Impact factor: 4.430

10.  Methylglyoxal-Dependent Glycative Stress and Deregulation of SIRT1 Functional Network in the Ovary of PCOS Mice.

Authors:  Giovanna Di Emidio; Martina Placidi; Francesco Rea; Giulia Rossi; Stefano Falone; Loredana Cristiano; Stefania Nottola; Anna Maria D'Alessandro; Fernanda Amicarelli; Maria Grazia Palmerini; Carla Tatone
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.